These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16723080)

  • 41. Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer.
    Yu H; Yuan J; Xiao C; Qin Y
    Int J Mol Med; 2013 May; 31(5):1248-54. PubMed ID: 23483216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
    Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
    Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of macrophage-stimulating protein by human airway trypsin-like protease.
    Orikawa H; Kawaguchi M; Baba T; Yorita K; Sakoda S; Kataoka H
    FEBS Lett; 2012 Feb; 586(3):217-21. PubMed ID: 22245154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.
    Bardella C; Costa B; Maggiora P; Patane' S; Olivero M; Ranzani GN; De Bortoli M; Comoglio PM; Di Renzo MF
    Cancer Res; 2004 Aug; 64(15):5154-61. PubMed ID: 15289319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON.
    Manzanares D; Monzon ME; Savani RC; Salathe M
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):160-8. PubMed ID: 17395888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.
    Chen YQ; Zhou YQ; Angeloni D; Kurtz AL; Qiang XZ; Wang MH
    Exp Cell Res; 2000 Nov; 261(1):229-38. PubMed ID: 11082293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
    Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
    Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo.
    Chen YQ; Zhou YQ; Fisher JH; Wang MH
    Oncogene; 2002 Sep; 21(41):6382-6. PubMed ID: 12214279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.
    Park JS; Khoi PN; Joo YE; Lee YH; Lang SA; Stoeltzing O; Jung YD
    Int J Oncol; 2013 Mar; 42(3):1120-6. PubMed ID: 23337910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
    Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR
    Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RON alternative splicing regulation in primary ovarian cancer.
    Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
    Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma.
    Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK
    Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine kinase receptor RON and its ligand MSP in Merkel cell carcinoma.
    Nagahama J; Daa T; Yada N; Kashima K; Fujiwara S; Saikawa T; Yokoyama S
    Pathol Res Pract; 2011 Aug; 207(8):463-7. PubMed ID: 21723047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells.
    Xia Y; Lian S; Khoi PN; Yoon HJ; Han JY; Chay KO; Kim KK; Jung YD
    Int J Oncol; 2015 Apr; 46(4):1835-43. PubMed ID: 25625479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
    Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
    J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
    Wang MH; Montero-Julian FA; Dauny I; Leonard EJ
    Oncogene; 1996 Nov; 13(10):2167-75. PubMed ID: 8950984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
    Huang L; Fang X; Shi D; Yao S; Wu W; Fang Q; Yao H
    Front Immunol; 2020; 11():569082. PubMed ID: 33117355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.
    Wang J; Rajput A; Kan JL; Rose R; Liu XQ; Kuropatwinski K; Hauser J; Beko A; Dominquez I; Sharratt EA; Brattain L; Levea C; Sun FL; Keane DM; Gibson NW; Brattain MG
    J Biol Chem; 2009 Apr; 284(16):10912-22. PubMed ID: 19224914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.
    Yoon TM; Kim SA; Park YL; Lee KH; Sung MW; Lee JK; Lim SC; Chung IJ; Joo YE
    Head Neck; 2013 Aug; 35(8):1106-13. PubMed ID: 22887469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.